|View printer-friendly version|
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
Logica, an offering from
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230914699514/en/
Under the collaboration, RS will work closely with the
“Partnering with the team at Related Sciences, we are excited to deploy Logica in the hunt for first-in-class therapeutics,” said
“Across our growing portfolio, Related Sciences brings together specialized technologies and orthogonal screening approaches that can maximize our chances of discovering transformational new medicines against high value targets,” said
Logica: Redefining Small Molecule Drug Discovery’s Gold Standard
Logica utilizes industry-leading predictive models, chemical design, and synthesis capabilities, DNA-encoded libraries, in silico high throughput screening from Valo’s Opal Computational Platform as well as Charles River’s leading capabilities in all aspects of discovery optimization including high throughput screening, medicinal chemistry, ADME, biology, pharmacology, and ultimately safety testing and IND submission, joining together for the first time to create a computation-powered, unified target-to-candidate offering.
Last year, Charles River and Flagship’s Pioneering Medicines announced an agreement to deploy Logica across a portfolio of targets with the aim of creating optimized small molecules that lead to novel therapies for unmet medical needs.
About Related Sciences
Related Sciences (RS) is a data science-driven drug discovery firm. RS uses a proprietary AI/ML platform to identify the best new drug discovery opportunities for every disease, assembles decentralized teams of top global researchers to guide the science, and then invests in and leads the efficient discovery of valuable new medicines via preclinical-specialized R&D platforms. RS is led by an interdisciplinary team of drug discovery, data science, and finance veterans and is backed by a luminary group of investors. www.related.vc
About Charles River
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Charles River Investor Contact:
Corporate Vice President, Investor Relations
Charles River Media Contact:
Corporate Vice President & Chief Communications Officer
Valo Health Media Contact:
Associate Director, Corporate Communications
Related Sciences Media Contact:
Founder and President